Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy
Clinical trial NCT01048255 · COMPLETED
Trial details
- NCT number
- NCT01048255
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.